Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
We posed the most common COVID-19 vaccine quandaries to Bryn Boslett, MD, an infectious disease expert who is leading the vaccination effort at UCSF. She explains why mRNA vaccines won’t affect your DNA, which allergies pose a risk, what 95 percent efficacy really means, and more.
The Regents’ vote follows more than two years of robust community engagement spanning 28 public meetings to develop the CPHP, which reflects input from hundreds of stakeholders inside and outside UCSF.
Scientific presentations will include advances in understanding the immune response, and precision medicine-driven development of new diagnostics, therapeutics, vaccines, and population health strategies.
Depression is among the most common psychiatric disorders, affecting as many as 264 million people worldwide and leading to hundreds of thousands of deaths per year. But as many as 30 percent of patients do not respond to standard treatments such as medication or psychotherapy.
UCSF, the San Francisco Building and Construction Trades Council, and Herrero Boldt Webcor have announced a Community Workforce Agreement that will promote collaboration between the University, labor unions and construction firms during the construction of the new hospital at UCSF Helen Diller Medical Center at Parnassus Heights.
A mutated version of the novel coronavirus has been making the news for being more contagious. We asked UCSF infectious disease expert Charles Chiu, MD, PhD, how the new variant emerged, whether available vaccines will still work, and what we need to do now.
UCSF scientists have discovered a new way to control the immune system’s “natural killer” cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection.